Seizures
Information
- Disease name
- Seizures
- Disease ID
- Description
Disease area statistics
Chromosome band
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05823168 | Active, not recruiting | Seizures and Traumatic Brain Injury Rehabilitation | January 1, 2021 | December 31, 2026 | |
NCT04244175 | Active, not recruiting | Phase 2 | A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | January 27, 2020 | July 2024 |
NCT04595786 | Active, not recruiting | N/A | The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection | October 30, 2020 | February 24, 2023 |
NCT04686786 | Active, not recruiting | Phase 2 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | December 8, 2020 | July 2025 |
NCT02813980 | Active, not recruiting | Neural Circulatory Control and SUDEP Risk. | June 2016 | December 2028 | |
NCT04259125 | Active, not recruiting | Evaluating the Role of Inflammation in Neonatal Epileptogenesis | December 15, 2018 | November 30, 2024 | |
NCT03529045 | Active, not recruiting | Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. | February 5, 2018 | April 30, 2025 | |
NCT00040326 | Completed | Phase 3 | Early Surgical Intervention to Treat Epilepsy | July 2002 | November 2007 |
NCT00041951 | Completed | Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study | December 1998 | July 2014 | |
NCT00067210 | Completed | Phase 2 | Reducing Seizure Frequency Using Cooling of the Head and Neck | August 11, 2003 | May 22, 2007 |
NCT00088452 | Completed | Phase 3 | Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study | July 2004 | August 31, 2016 |
NCT00113815 | Completed | Phase 3 | Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures | May 2005 | November 2007 |
NCT00141427 | Completed | Phase 4 | Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial. | November 2004 | May 2006 |
NCT00143130 | Completed | Phase 3 | Pregabalin In Partial Seizures Extension Study | April 2005 | September 2007 |
NCT00147030 | Completed | N/A | TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia | December 2002 | August 2008 |
NCT00162981 | Completed | Phase 2 | Clobazam in Subjects With Lennox-Gastaut Syndrome | October 2005 | October 2006 |
NCT06451289 | Completed | Study on Optic Nerve Sheath Diameter Measurements in Prolonged Pediatric Seizures | September 1, 2020 | December 1, 2022 | |
NCT00224952 | Completed | Pathogenesis of Adverse Drug Reactions | July 2002 | March 2010 | |
NCT00230698 | Completed | Phase 3 | A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure | November 1995 | August 2002 |
NCT00231556 | Completed | Phase 3 | A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy | July 1999 | September 2003 |
NCT00232596 | Completed | Phase 3 | Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy | September 2005 | January 2008 |
NCT00233012 | Completed | Phase 1 | A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures | June 2005 | October 2007 |
NCT00235755 | Completed | Phase 3 | Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy | December 2005 | April 2008 |
NCT00236418 | Completed | Phase 3 | A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures | December 1994 | December 1996 |
NCT00236691 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. | July 1988 | December 1990 |
NCT00236704 | Completed | Phase 3 | A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures | March 1994 | December 1999 |
NCT00236717 | Completed | Phase 3 | A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy | September 1997 | November 2000 |
NCT00236730 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy | June 1988 | December 1990 |
NCT00236743 | Completed | Phase 3 | A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy | June 1994 | October 2000 |
NCT00236756 | Completed | Phase 3 | A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome | August 1993 | February 2001 |
NCT00236847 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. | December 1989 | July 1993 |
NCT00236860 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures | May 1989 | February 1992 |
NCT00236873 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. | October 1989 | May 1993 |
NCT00236886 | Completed | Phase 3 | Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients | May 1998 | June 2000 |
NCT00266591 | Completed | Phase 3 | A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy | October 1992 | April 1997 |
NCT00266604 | Completed | Phase 4 | A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy | December 2005 | June 2007 |
NCT00297349 | Completed | A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures | November 2003 | June 2005 | |
NCT00298246 | Completed | Clinical and Immunological Investigations of Subtypes of Autism | February 22, 2006 | March 15, 2017 | |
NCT00318929 | Completed | N/A | Tolerability and Efficacy of Depakote-extended Release in the Elderly | April 2006 | January 2008 |
NCT00319501 | Completed | Phase 3 | Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. | January 2006 | July 2014 |
NCT00326612 | Completed | Phase 2 | Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures | June 2006 | December 2008 |
NCT00345475 | Completed | UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry) | December 2004 | May 2016 | |
NCT00361010 | Completed | N/A | A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy | December 2006 | December 2007 |
NCT06271096 | Completed | Early Phase 1 | Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children | November 1, 2019 | January 1, 2024 |
NCT00518713 | Completed | Phase 3 | Clobazam in Patients With Lennox-Gastaut Syndrome | August 2007 | April 2010 |
NCT00534378 | Completed | Phase 1 | Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector | July 2006 | December 2006 |
NCT00616681 | Completed | N/A | Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions | June 2004 | July 2004 |
NCT00616863 | Completed | N/A | Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions | July 2004 | July 2004 |
NCT00618046 | Completed | N/A | Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions | November 2004 | November 2004 |
NCT00697918 | Completed | Phase 3 | Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures | March 2008 | April 2009 |
NCT00735527 | Completed | Phase 3 | Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children | May 2008 | April 2009 |
NCT00789113 | Completed | Phase 1/Phase 2 | Determination of Absorption and Elimination of Lamotrigine-XR | November 2008 | January 2011 |
NCT00826722 | Completed | N/A | Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions | June 2007 | June 2007 |
NCT00826787 | Completed | N/A | Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions | August 2005 | August 2005 |
NCT00826865 | Completed | N/A | Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions | August 2005 | August 2005 |
NCT00827320 | Completed | N/A | Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions | June 2007 | June 2007 |
NCT00830531 | Completed | Phase 1 | Pilot Study of Bumetanide for Newborn Seizures | January 2010 | January 2019 |
NCT00864006 | Completed | Phase 1 | Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions | October 2006 | October 2006 |
NCT00884052 | Completed | Phase 1/Phase 2 | Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures | April 2007 | October 2011 |
NCT00884351 | Completed | Magnetoencephalography in Absence Seizures | April 15, 2009 | June 15, 2011 | |
NCT00887861 | Completed | Phase 2 | Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery | March 2009 | August 2010 |
NCT01027715 | Completed | N/A | The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy | January 2010 | December 2015 |
NCT01030094 | Completed | A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy | February 2007 | April 2009 | |
NCT01236001 | Completed | Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older | September 2010 | March 2012 | |
NCT01239212 | Completed | Phase 1/Phase 2 | Dosing of Levetiracetam (Keppra) in Neonates | September 2010 | July 2011 |
NCT01261416 | Completed | Pharmacokinetics of Levetiracetam (Keppra) in Neonates | October 2008 | July 2010 | |
NCT00001912 | Completed | Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis | August 10, 1999 | April 4, 2012 | |
NCT00007670 | Completed | Phase 3 | Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. | January 1998 | March 2003 |
NCT03534258 | Completed | Does Use of Rapid Response EEG Impact Clinical Decision Making | April 30, 2018 | July 31, 2019 | |
NCT03561168 | Completed | Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years | October 12, 2017 | June 15, 2018 | |
NCT03656939 | Completed | A Safety Study For Prevenar 13 Among Chinese Children | August 1, 2018 | July 31, 2020 | |
NCT03722212 | Completed | N/A | Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test | September 24, 2018 | July 9, 2021 |
NCT03754582 | Completed | Phase 2 | A Study of Intravenous Perampanel in Japanese Participants With Epilepsy | November 27, 2018 | December 10, 2019 |
NCT03892798 | Completed | Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene | November 27, 2018 | May 17, 2024 | |
NCT03209323 | Completed | N/A | Epileptiform EEG Patterns During Induction of General Anaesthesia With Sevoflurane Compared to Those With Propofol | January 1, 2007 | December 13, 2008 |
NCT00001666 | Completed | Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy | March 1997 | June 2002 | |
NCT03360656 | Completed | N/A | Transnasal Induction of Normothermia in Febrile Stroke Patients | January 16, 2018 | April 22, 2022 |
NCT03826056 | Completed | N/A | Neurology Inpatient Clinical Education Trial | February 1, 2019 | December 7, 2021 |
NCT03399318 | Completed | Phase 2 | Aggressive Antipyretics for Fever Reduction in CNS Malaria | January 7, 2019 | December 2, 2022 |
NCT00004729 | Completed | N/A | Ketogenic Diet for Child Epilepsy and Seizure Control | July 1997 | |
NCT01338363 | Completed | Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists | May 2011 | August 2015 | |
NCT00001149 | Completed | Monitoring Patients With Uncontrolled Epilepsy | November 1975 | January 2002 | |
NCT01415362 | Completed | N/A | Closed-loop System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy | July 2011 | July 2014 |
NCT01431326 | Completed | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | November 2011 | November 2019 | |
NCT01459692 | Completed | N/A | Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps | February 2005 | January 2008 |
NCT05103735 | Completed | Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity | September 15, 2021 | October 11, 2021 | |
NCT01515436 | Completed | N/A | The Effect of Music Periodicity on Interictal Epileptiform Discharges | February 2004 | December 2007 |
NCT01554683 | Completed | N/A | Seizure Activity in Alzheimer's Disease | February 2012 | July 1, 2017 |
NCT01702623 | Completed | Phase 1 | Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions | September 2009 | September 2009 |
NCT01703468 | Completed | Phase 1 | Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions | September 2009 | October 2009 |
NCT01774500 | Completed | Biomarkers In Seizure To Predict Recurrence and Severe Outcomes | January 2013 | March 2014 | |
NCT01855178 | Completed | Pediatric Seizure Movement Bed Alarm | October 2010 | June 2015 | |
NCT01856335 | Completed | Early Phase 1 | Exercise Education for Adults With Seizure Disorders | May 10, 2013 | December 7, 2018 |
NCT01897974 | Completed | Revisiting Survey Investigating Why Patients Are Not Receiving Home Anti-convulsant Medication Prior to Surgery/or Procedure Involving General Anesthesia | June 2013 | June 2014 | |
NCT04511676 | Completed | The Study of Pharmacokinetics of Levetiracetam in Patients Undergoing Intermittent Hemodialysis | November 1, 2018 | October 10, 2019 | |
NCT04497142 | Completed | Phase 1/Phase 2 | Effect of Perampanel on Peritumoral Hyperexcitability in HGG | November 5, 2020 | May 16, 2023 |
NCT02019667 | Completed | Phase 2 | Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency | March 31, 2014 | April 3, 2019 |
NCT04439656 | Completed | Detecting Absence Seizures Using Eye Tracking | July 15, 2020 | June 28, 2022 | |
NCT00001192 | Completed | Neuropsychological Evaluation of Psychiatric and Neurological Patients | October 18, 1983 | December 20, 2006 | |
NCT04426994 | Completed | Hypomagnesemia Associated With Proton-Pump Inhibitor Use | January 31, 2017 | September 30, 2019 | |
NCT02318602 | Completed | Phase 3 | Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder | January 8, 2016 | June 22, 2017 |
NCT02324673 | Completed | Phase 1/Phase 2 | Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders | April 13, 2015 | May 9, 2016 |
NCT02332174 | Completed | Phase 1 | Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects | March 2014 | June 2014 |
NCT04325685 | Completed | N/A | The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia | January 1, 2020 | November 7, 2023 |
NCT02385526 | Completed | Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation | April 28, 2015 | October 10, 2016 | |
NCT04323150 | Completed | N/A | The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. | February 1, 2018 | December 31, 2020 |
NCT02431780 | Completed | N/A | A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection | February 12, 2015 | February 7, 2017 |
NCT02458820 | Completed | N/A | Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest | June 2015 | January 2019 |
NCT02544750 | Completed | Phase 3 | An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | August 31, 2016 | June 11, 2021 |
NCT02544763 | Completed | Phase 3 | A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | April 6, 2016 | February 26, 2019 |
NCT00001325 | Completed | Metabolic Abnormalities in Children With Epilepsy | April 1992 | June 2004 | |
NCT04202159 | Completed | A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures | January 21, 2020 | March 31, 2023 | |
NCT02695537 | Completed | Phase 1 | University of Alabama at Birmingham (UAB) Pediatric CBD Program | April 2015 | February 27, 2019 |
NCT02700412 | Completed | Phase 1 | University of Alabama at Birmingham (UAB) Adult CBD Program | April 2015 | August 8, 2019 |
NCT02761330 | Completed | N/A | Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia | April 2016 | September 11, 2019 |
NCT00001366 | Completed | Mapping the Areas of the Brain Associated With Language in Children With Epilepsy | August 1993 | September 2002 | |
NCT04141891 | Completed | N/A | Advancing Understanding of Transportation Options | December 12, 2019 | December 21, 2023 |
NCT02881957 | Completed | Phase 2/Phase 3 | Hypovitaminosis D in Neurocritical Patients | October 10, 2016 | October 10, 2018 |
NCT02897856 | Completed | Phase 4 | Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures | September 2016 | November 2018 |
NCT04022486 | Completed | Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis | April 1, 2018 | May 1, 2019 | |
NCT03103425 | Completed | Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings | June 2009 | June 1, 2014 | |
NCT05422664 | Enrolling by invitation | Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy | January 1, 2018 | December 31, 2025 | |
NCT04998123 | Not yet recruiting | N/A | Efficacy of Intersectional Short Pulse Stimulation for Terminating Seizures | January 2025 | December 2026 |
NCT05897658 | Not yet recruiting | Phase 3 | Levetiracetam Prophylaxis in Brain Tumor Resection Pilot | June 2024 | July 2024 |
NCT06375395 | Not yet recruiting | N/A | Boosting The Intervention Effect of Negative Memory Through tACS Stimulation | May 15, 2024 | December 31, 2024 |
NCT06442748 | Not yet recruiting | Phase 3 | Short Versus Long-term Levetiracetam in Brain Tumors | June 1, 2024 | June 1, 2031 |
NCT06045676 | Not yet recruiting | Electrocardiographic Changes Among Epileptic and Non Epileptic Seizures in Children at Sohag University Hospital | September 25, 2023 | September 25, 2024 | |
NCT05649891 | Not yet recruiting | N/A | Checklists Resuscitation Emergency Department | September 2023 | March 2024 |
NCT05140265 | Recruiting | De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information | October 11, 2021 | December 31, 2030 | |
NCT02216500 | Recruiting | N/A | Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy | September 2006 | October 2031 |
NCT02552511 | Recruiting | Epidemiology Study on Neonatal Seizure | September 1, 2015 | December 30, 2025 | |
NCT02824822 | Recruiting | Genetic Markers of Cardiovascular Disease in Epilepsy | May 2016 | December 2029 | |
NCT03233399 | Recruiting | N/A | Modulating Movement Intention Via Cortical Stimulation | July 20, 2017 | May 2025 |
NCT03419260 | Recruiting | Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children | March 13, 2017 | January 1, 2027 | |
NCT03478852 | Recruiting | Investigating Epilepsy: Screening and Evaluation | March 28, 2018 | July 30, 2027 | |
NCT03492060 | Recruiting | A Natural History Study of hnRNP-related Disorders | June 13, 2018 | April 2024 | |
NCT03822741 | Recruiting | Etiology and Treatment of Neonatal Seizure | August 8, 2016 | December 30, 2026 | |
NCT03934268 | Recruiting | A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy | January 1, 2017 | December 2023 | |
NCT03944447 | Recruiting | Phase 2 | Outcomes Mandate National Integration With Cannabis as Medicine | December 1, 2018 | December 31, 2025 |
NCT04076449 | Recruiting | Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy | September 3, 2019 | December 31, 2026 | |
NCT04737369 | Recruiting | Multimodal Neuromonitoring | December 1, 2020 | December 1, 2025 | |
NCT04770337 | Recruiting | N/A | Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy | October 25, 2021 | December 2024 |
NCT05121324 | Recruiting | Phase 3 | Pediatric Dose Optimization for Seizures in Emergency Medical Services | August 8, 2022 | September 30, 2026 |
NCT05219617 | Recruiting | Phase 3 | Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults | April 28, 2022 | June 2026 |
NCT05339126 | Recruiting | Phase 2 | RNS System LGS Feasibility Study | October 4, 2022 | May 31, 2027 |
NCT05594017 | Recruiting | Early Phase 1 | Pharmacological Modulation of Brain Oscillations in Memory Processing | August 1, 2019 | November 30, 2026 |
NCT05738226 | Recruiting | N/A | EpiCare@Home Validation Study for Focal Onset Seizures | January 23, 2023 | December 2023 |
NCT05761756 | Recruiting | N/A | Oxygen Toxicity: Mechanisms in Humans | November 28, 2023 | March 2026 |
NCT05772429 | Recruiting | Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting | April 17, 2023 | March 1, 2025 | |
NCT05851391 | Recruiting | Phase 2 | buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest | August 7, 2023 | April 30, 2025 |
NCT05864547 | Recruiting | Predisposing Factors for Post-stroke Epilepsy | May 8, 2023 | December 2030 | |
NCT06027749 | Recruiting | N/A | Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System. | October 13, 2023 | June 1, 2024 |
NCT06038513 | Recruiting | N/A | Transnasal Induction of Normothermia for Neurogenic Fever | November 21, 2023 | November 2024 |
NCT06067750 | Recruiting | Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation | June 27, 2023 | June 30, 2024 | |
NCT06093490 | Recruiting | Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings | December 1, 2023 | December 1, 2024 | |
NCT06129760 | Recruiting | N/A | Glioblastoma Remote Monitoring and Care - Research Protocol | April 30, 2024 | January 1, 2027 |
NCT06426615 | Recruiting | N/A | Connectivity and Neural Signatures of Consciousness in Unresponsive States | January 1, 2024 | December 31, 2027 |
NCT04193891 | Suspended | The Effect of Ketogenic Dietary Therapy on Sleep in Adult Epilepsy | February 12, 2020 | December 2025 | |
NCT05784805 | Suspended | N/A | Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients | June 24, 2023 | March 2024 |
NCT02349087 | Terminated | EEG in Resuscitated In-hospital Patients | December 2014 | December 31, 2020 | |
NCT01974700 | Terminated | Phase 4 | Seizure Prophylaxis in Aneurysm Repair | July 2013 | February 2016 |
NCT01721317 | Terminated | Phase 4 | Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures | December 19, 2012 | June 20, 2013 |
NCT01496612 | Terminated | Phase 2 | Buspirone Therapy for Localized Epilepsy | November 22, 2011 | April 19, 2016 |
NCT01478035 | Terminated | Phase 4 | Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old. | November 2011 | December 2015 |
NCT00697762 | Terminated | Phase 3 | Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures | October 2007 | May 2008 |
NCT01363154 | Terminated | N/A | Prevention of Photoparoxysmal Abnormalities by Mozart K448 | November 2010 | February 2013 |
NCT00439387 | Terminated | The Role of Serotonin in Seizures | February 20, 2007 | June 5, 2015 | |
NCT00219479 | Terminated | Phase 4 | Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study | August 1997 | December 2007 |
NCT03790436 | Terminated | N/A | Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet | September 14, 2018 | December 31, 2021 |
NCT00563459 | Terminated | Phase 3 | Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy. | November 2007 | April 2010 |
NCT03954314 | Terminated | Phase 3 | DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery | September 17, 2019 | November 28, 2023 |
NCT02451618 | Terminated | Novel Epidermal Recording and Detection of Seizures | January 27, 2015 | ||
NCT02409433 | Terminated | Phase 4 | Comparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management | August 2014 | November 2015 |
NCT01320670 | Unknown status | Neuroimaging Predictors of Treatment Failure in Adult New-onset Epilepsy | June 2011 | December 2014 | |
NCT03753035 | Unknown status | Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children | November 29, 2018 | September 30, 2019 | |
NCT00516334 | Unknown status | Study of Bedside EEG to Evaluate Brain Injury in Premature Newborns | May 2006 | May 2013 | |
NCT04879147 | Unknown status | Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Syncopation and Seizure | May 5, 2021 | May 13, 2024 | |
NCT04885075 | Unknown status | Phase 4 | Comparing the Efficacy of Intranasal Midazolam Versus Intravenous Diazepam for Control of Seizures in Children | May 30, 2021 | November 30, 2021 |
NCT04118829 | Unknown status | Phase 4 | Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER | November 1, 2019 | March 2023 |
NCT02850913 | Unknown status | Phase 2 | Doxycycline for the Treatment of Nodding Syndrome | September 5, 2016 | August 5, 2020 |
NCT02661919 | Unknown status | N/A | Assessment of the Emfit Mattress Sensor for Detection and Alarm of Night-time Generalized Tonic-clonic Seizures. | October 1, 2019 | June 30, 2020 |
NCT04211233 | Unknown status | N/A | Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE) | December 20, 2019 | December 30, 2020 |
NCT02436616 | Unknown status | microEEG for Neonatal Apnea, Bradycardia and Desaturation | January 2013 | July 2016 | |
NCT03369522 | Unknown status | Development of an Epileptic Seizure Detection Algorithm by Continuous Analysis of the Electrocardiogram | December 13, 2017 | December 2021 | |
NCT03181945 | Unknown status | N/A | Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome | May 1, 2016 | February 28, 2019 |
NCT01126307 | Unknown status | N/A | Study of Verapamil in Refractory Epilepsy | June 2010 | December 2012 |
NCT04291716 | Unknown status | N/A | Study to Validate Novel Seizure-Detection Algorithm | March 2020 | December 2020 |
NCT03054285 | Unknown status | Phase 4 | Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates? | July 1, 2017 | April 1, 2021 |
NCT02298647 | Withdrawn | Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) | August 20, 2018 | February 28, 2021 | |
NCT04102254 | Withdrawn | N/A | Thalamic Stimulation for Epilepsy Study | January 7, 2023 | January 10, 2025 |
NCT01730001 | Withdrawn | N/A | Early Versus Late Intubation Trial in Physician Manned Emergency Medical Services | January 1, 2015 | March 28, 2017 |
NCT00465244 | Withdrawn | Phase 2/Phase 3 | Seizure Therapy With Intravenous Levetiracetam and Lorazepam | January 2008 | May 2010 |
NCT02054949 | Withdrawn | N/A | Treatment Resistant Epilepsy and N-Acetyl Cysteine | April 2013 | January 2015 |
NCT00279851 | Withdrawn | Blood Sugars in Children With Idiopathic Seizures. | February 2006 | February 2007 | |
NCT01935908 | Withdrawn | Phase 4 | Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study | May 2013 | May 2013 |
- HPO alt_id (Human Phenotype Ontology)
- HP:0001275
- HPO alt_id (Human Phenotype Ontology)
- HP:0001303
- HPO alt_id (Human Phenotype Ontology)
- HP:0002125
- HPO alt_id (Human Phenotype Ontology)
- HP:0002182
- HPO alt_id (Human Phenotype Ontology)
- HP:0002279
- HPO alt_id (Human Phenotype Ontology)
- HP:0002306
- HPO alt_id (Human Phenotype Ontology)
- HP:0002348
- HPO alt_id (Human Phenotype Ontology)
- HP:0002391
- HPO alt_id (Human Phenotype Ontology)
- HP:0002417
- HPO alt_id (Human Phenotype Ontology)
- HP:0002430
- HPO alt_id (Human Phenotype Ontology)
- HP:0002431
- HPO alt_id (Human Phenotype Ontology)
- HP:0002432
- HPO alt_id (Human Phenotype Ontology)
- HP:0002434
- HPO alt_id (Human Phenotype Ontology)
- HP:0002437
- HPO alt_id (Human Phenotype Ontology)
- HP:0002466
- HPO alt_id (Human Phenotype Ontology)
- HP:0002479
- HPO alt_id (Human Phenotype Ontology)
- HP:0002794
- HPO alt_id (Human Phenotype Ontology)
- HP:0006997
- HPO alt_id (Human Phenotype Ontology)
- HP:0010520
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001250
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012640